Linda Liau
Career Enhancement Program Director · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · · · · ·
History
PresentCareer Enhancement · UCLA David Geffen School of Medicine/UCLA Medical Center
- 2019–Present
American Board of Neurological Surgery
- 2017–Present
UCLA Department of Neurosurgery
UCLA Anderson School of Management
Research
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Nature · 2009 · 3,172 citations
Nature Medicine · 2019 · 1,142 citations
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
New England Journal of Medicine · 2005 · 1,134 citations
136 papers
86 papers
81 papers · 2 as a fellow
58 papers
51 papers
44 papers
39 papers · 12 as a resident
28 papers
Grants
- 2017–2027
National Cancer Institute · P50
Contact PI · $22.6M · University of California Los Angeles
- 2012–2022
UCLA Neurosurgery Research Training and Education Program
National Institute of Neurological Disorders and Stroke · R25
Contact PI · $1.2M · University of California Los Angeles
- 2010–2016
Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas
National Cancer Institute · R01
Contact PI · $2.4M · University of California Los Angeles
- 2006–2012
Dendritic Cell Vaccine Targeting Melanoma-Associated Antigens in Malignant Glioma
National Cancer Institute · R01
Contact PI · $1.3M · University of California Los Angeles
Clinical trials
- 2006
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Principal investigator · Unknown · Phase 3
Northwest Biotherapeutics
- 2006–2012
Vaccine Therapy in Treating Patients With Malignant Glioma
Principal investigator · Completed · Phase 1
Jonsson Comprehensive Cancer Center
- 2003–2012
Vaccine Therapy in Treating Patients With Malignant Glioma
Principal investigator · Completed · Phase 1
Jonsson Comprehensive Cancer Center
Site PI · Available
Northwest Biotherapeutics